Dialysis world news


Add kidneys to list of things that can be recycled - Zee News
Add kidneys to list of things that can be recycled Chicago: It turns out you can recycle just about anything these days — even kidneys and other organs donated for transplants.

Recently in Chicago, in what is believed to be the first documented case of its kind in the US, a transplanted kidney that was failing was removed from a patient while he was still alive and given to somebody else.

There have been other cases since the 1980s of transplant organs being used more than once, but they were rare and involved instances in which the first recipient died.

Typically when transplanted organs fail in living patients, doctors throw them away. But with more than 73,000 people awaiting transplants nationwide, some specialists say doctors should consider trying to reuse more organs to ease the severe shortage.

"The need for kidney transplantation doesn`t match our capacity," said Dr. Lorenzo Gallon, a Northwestern University transplant specialist who oversaw the kidney recycling operation in Chicago. "People die on dialysis" while awaiting kidneys.

That was the possible fate awaiting two strangers. A research letter describing the unusual case was published in Thursday`s New England Journal of Medicine.

The donated kidney lasted just two weeks in the first patient, a 27-year-old Illinois man. The same disease that ruined his kidneys started to damage the new kidney, given to him by his sister. He was getting sicker, and doctors needed to act fast if they were going to save the organ. With permission from the man and his sister, they removed it last July and retransplanted it into a 67-year-old Indiana man.

The Illinois man is back on dialysis and will probably get another transplant eventually.

Still, reusing a transplanted organ can be tricky — and riskier — because surgeons have to deal with scar tissue that typically forms around an organ as the body heals from the operation.

Also, Wayne Shelton, a bioethicist at Albany Medical College in New York, said the practice may raise ethical questions. He said doctors need to make sure patients who are offered reused parts understand all the risks and are not made to feel coerced into accepting such organs. And because these cases are so rare, there is little data on how patients with recycled parts fare, Shelton noted.

Dr. Jonathan Bromberg, director of transplantation at the University of Maryland Medical Center, praised the Northwestern doctors but said organ recycling is unlikely to become commonplace because it would be rare for an already transplanted organ to be healthy enough to be reused.

In Boston in 2009, a man died shortly after a getting a new heart, and the organ was in good enough shape to be transplanted into someone else. A 2005 medical journal report detailed three US cases involving donor livers reused after the initial recipients died, and said they were among 11 similar cases between 1987 and 2005. Medical literature also includes reports from the 1990s about a kidney retransplant in Spain and a heart retransplant in Switzerland.

In the Chicago case, Ray Fearing of Arlington Heights, Ill., received a new kidney that was later reused by Erwin Gomez of Valparaiso, Ind., a surgeon familiar with the medical complexities involved.

Joel Newman, a spokesman for the United Network for Organ Sharing, said previous retransplants in the US "have occurred when the original recipient has died soon after a transplant but the organ is still able to function. To our knowledge, this is the first publicly reported instance where a kidney has been removed from a living person due to the risk of organ failure and retransplanted."

Fearing had a disease that caused scarring that prevented the kidneys from filtering waste from blood. He had to quit his industrial machinery job and went on dialysis a year ago. His sister donated a kidney last June in what was "probably the happiest moment of my life," Fearing said. The worst, he said, was a few days later, when doctors told him the kidney was damaged and had to be removed.

Gallon, medical director of Northwestern`s kidney transplant program, thought the kidney could be reused in somebody else if it was removed quickly, before it became irreversibly damaged.

Gallon needed Fearing`s permission, and also asked the young man`s sister, Cera Fearing.

Fearing said he was heartbroken and reluctant to abandon an organ that had been his only hope for a normal life. But he decided it was the only option that made sense. His sister, too, was crushed but said she didn`t hesitate when told her kidney might help someone else.

"I just assumed it`s damaged, it`s garbage," she said. "The fact that they were able to give it to someone that somehow was able to benefit from it was great."

Gomez was selected because he was a good match. But Gallon said doctors also thought Gomez`s medical background would help him understand the complexities. Gomez said he had never heard of reusing transplant organs, and he worried about taking what seemed like damaged goods. But he agreed after the Northwestern team explained the risks and possible benefits.

The removal and retransplant operations took place July 1. Within two days, the transplanted kidney had regained function. Gallon said he is convinced the damage is reversed.

Gomez is taking anti-rejection drugs and is off dialysis. "I finally feel normal," he said. Fearing is back on dialysis and said he is doing OK.

Gallon said it is not uncommon for patients with Fearing`s disease to go through more than one transplanted kidney, and he expects Fearing will eventually get another one.

Despite his own misfortune, Fearing said he is "extremely happy about being a part of this medical breakthrough" that might end up helping others.

Bureau Report

...

 
KCB boost for hospital - The Star

The Kenya Commercial Bank Foundation has launched a campaign against preventable non-communicable and lifestyle diseases that have become a leading cause of death in the country. The KCB Foundation over the weekend donated a dialysis machine valued at Sh1.9 million to the Nyanza Provincial General Hospital.

The donation forms part of the foundation long-term programme that seeks to ensure all provincial hospitals in the country have trained personnel and functional and equipped renal units.

The foundation chairperson Susan Omanga said the foundation has committed Sh15 million towards equipping government hospitals across the country with dialysis machines. This is  part of Sh400 million the foundation will spend on corporate activities.

“We are now working with Kenyatta National Hospital  where we donated three machines to their renal unit last year. Wwe have since realized that the main challenge for patients on dialysis is the limited access and high costs of treatment and high dependence on Kenyatta and that is why we want to spread the service across other hospital”, she said.

“The most affordable treatment is in government hospitals but only a few of them have dialysis machines,” she said. Health practitioners say that lifestyle diseases such as high blood pressure; heart diseases, diabetes and cancer are today the leading causes of death in Kenya.

The diseases also account for half of all hospital admissions. Every year, over 28,000 Kenyans are diagnosed with cancer while more than half of them die from lack of treatment due to high costs.

In Kenya over 10 percent of the general population are suffering from Kidney disease while only 13 dialysis are available across the country to cater for their medical needs. “The Foundation is investing in dialysis machines as part of the curative intervention for non-Communicable diseases thus ensuring accessible and affordable quality treatment and care to patients suffering from lifestyle diseases, as well as bringing treatment closer to patients and relieving them of their suffering”, said Omanga.

According to world health organization records, Kenya is the deaths associated with lifestyle clocked 3000 in 2011 bringing the country to position 77 in lifestyle disease incidents.


 

...

 
PTH Rise in CKD Greater in Blacks - Renal and Urology News

Parathyroid hormone (PTH) levels increase with progressive stages of chronic kidney disease (CKD) significantly more in African Americans (AA) than in patients of other races, new study findings suggest. This racial difference is apparent as early as stage 2 CKD.

In addition, the study demonstrated that only a moderate component of the PTH increase in AA is explained by changes in serum calcium, phosphorus, and 25-hydroxyvitamin D (25-D), according to a report in Nephrology Dialysis Transplantation (published online ahead of print). The findings are important “because PTH is used as a gauge of CKD mineral bone disorder, a gauge that can drive therapeutic interventions,” the researchers wrote. “Almost certainly, the weight of evidence suggests that use of this gauge must be selective in relation to AA race, an issue that has not yet been addressed in any clinical guidelines.”

Jennifer Ennis, MD, of Litholink Corp., Chicago, a subsidiary of LabCorp, and colleagues analyzed data from 2,028 CKD patients from primary care and nephrology practices across the United States. Of the 2,028 patients, 505 were AA.

The mean PTH was significantly higher for AA than for non-AA in each successive stage of CKD, beginning with stage 2. Results showed that 25-D levels were significantly higher for non-AA in CKD stages 1-3. Serum calcium and phosphorus did not differ between the groups at any stage. Serum calcium, phosphorus, and 25-D were inversely correlated with PTH levels regardless of race, but all factors combined accounted for approximately 42% of the variance in PTH, Dr. Ennis' group reported.

The new findings supplement those of previous studies. For example, in a study of 218 patients in an ethnically diverse ambulatory nephrology practice at the University of California-San Francisco, Ian H. De Boer, MD, and colleagues found that the adjusted mean PTH was significantly higher among AA compared with whites (233 vs. 139 pg/mL). Among patients with an estimated glomerular filtration rate (GFR) below 60 mL/min/1.73 m2, the slope of GFR vs. PTH was significantly steeper among AA than whites, according to a report in the Journal of the American Society of Nephrology (2002;13:2762-2769).

Dr. Ennis and her group pointed to some important limitations of their study. For example, urine data and information on diet were unavailable, and medication information was unavailable for only 42% of cases. The researchers did not have information about socioeconomic status, body mass index, and smoking status.

Furthermore, they noted that because of the cross-sectional design of the study, patients may have been at various stages of treatment of CKD mineral bone disorder. “Consequently, the ability to generalize about the natural history of CKD and its implications on mineral metabolism is limited,” they wrote.

...

 
26/04/2012Fresenius Medical Care confirms full-year outlook - Expatica Germany

Fresenius Medical Care (FMC), the world's leading supplier of renal care products and services, said Thursday it was confirming its outlook for the current year after a strong first quarter.

FMC, which publishes its accounts in US dollars, said in a statement that bottom-line net profit soared by 68 percent to $370 million (279 million euros) in the period from January to March on a 9.0-percent increase in sales to $3.249 billion.

The net profit figure was, however, inflated by an investment gain of $127 million related to the acquisition of Liberty Dialysis holdings, the statement explained.

Excluding this one-off factor, net profit grew by 10 percent to $244 million.

On the back of this "strong operating performance," FMC said it was sticking to its forecast for full-year sales of around $14 billion and net profit, excluding the investment gain, of $1.14 billion.

In 2011, FMC booked a record net profit of $1.071 million on sales of $12.795 billion.

Separately, FMC's parent company, healthcare group Fresenius, said it was launching a 3.1-billion-euro takeover bid for one of Germany's largest private hospital operators Rhoen-Klinikum AG.

Rhoen-Klinikum has annual sales of 2.6 billion euros and net profit of 161 million euros and operates some 53 hospitals with around 16,000 beds.

Fresenius plans to merge it with its HELIOS group of hospitals to create the country's largest private hospital operator.

Fresenius, which publishes its accounts in euros, said it, too, got off to an "excellent" start to 2012, with net profit jumping 18 percent to 200 million euros on a 13-percent increase in sales to 4.419 billion euros in the first three months.

On the basis of that strong performance, Fresenius said it was raising its full-year forecasts and was now projecting net income growth of 12-15 percent, instead of eight-12 percent previously.

Sales were expected to come out at the upper end of the forecast range of 10-13 percent, Fresenius added.

In 2011, Fresenius booked net profit of 770 million euros on sales of 16.5 billion euros.

...

 
Fresenius Medical Care 1Q Net Profit $370 Million, Backs Outlook - Fox Business

FRANKFURT –  Fresenius Medical Care AG & Co. KGaA, the world's largest provider of dialysis products and services, said Thursday its earnings rose strongly in the first quarter helped by an investment gain, and backed its outlook for 2012.

MAIN FACTS:

- Based on preliminary data, total revenue for the first quarter increased by 9% (10% at constant currency) to $3.25 billion.

-Operating income rose by 13% to $503 million. This resulted in an operating margin of 15.5% for the first quarter of 2012 compared to 14.9% for the corresponding quarter in 2011.

-Net income attributable to shareholders of Fresenius Medical Care for the first quarter was $370 million, an increase of 68%. This includes a non-taxable investment gain of $127 million related to the acquisition of Liberty Dialysis Holdings, Inc., including its 51% stake in Renal Advantage Partners, LLC. The gain is a result of measuring the 49% equity interest in RAI held by the company at its fair value at the time of the Liberty acquisition and is subject to the finalization of the Liberty purchase accounting.

-Excluding this investment gain, net income attributable to shareholders of Fresenius Medical Care AG & Co. KGaA increased by 10% to $244 million.

-For the full year 2012, the company confirms its sales and earnings outlook.

-The company expects revenue to grow to around $14 billion in 2012.

-Net income attributable to shareholders of Fresenius Medical Care AG & Co. KGaA is expected to grow to around $1.14 billion. This does not include the investment gain in the amount of approximately $127 million in the first quarter of 2012.

-Frankfurt Bureau, Dow Jones Newswires; 49-69-29725-500

Order free Annual Report for Fresenius Medical Care AG & Co. KGaA

Visit http://djnweurope.ar.wilink.com/?ticker=DE0005785802 or call +44 (0)208 391 6028

Copyright © 2012 Dow Jones Newswires

...

 
<< Start < Prev 421 422 423 424 425 426 427 428 429 430 Next > End >>

Page 427 of 2630
Share |
Copyright © 2024 Global Dialysis. All Rights Reserved.